Compare SUVEN LIFE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES GSK PHARMA SUVEN LIFESCIENCES/
GSK PHARMA
 
P/E (TTM) x 20.1 56.7 35.4% View Chart
P/BV x 4.1 11.9 34.1% View Chart
Dividend Yield % 0.5 1.3 39.1%  

Financials

 SUVEN LIFESCIENCES   GSK PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
GSK PHARMA
Mar-19
SUVEN LIFESCIENCES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3383,595 9.4%   
Low Rs1691,253 13.5%   
Sales per share (Unadj.) Rs52.1184.7 28.2%  
Earnings per share (Unadj.) Rs6.826.3 26.0%  
Cash flow per share (Unadj.) Rs8.629.2 29.4%  
Dividends per share (Unadj.) Rs1.5020.00 7.5%  
Dividend yield (eoy) %0.60.8 71.7%  
Book value per share (Unadj.) Rs65.3126.3 51.7%  
Shares outstanding (eoy) m127.28169.40 75.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.913.1 37.1%   
Avg P/E ratio x37.192.2 40.3%  
P/CF ratio (eoy) x29.683.1 35.6%  
Price / Book Value ratio x3.919.2 20.2%  
Dividend payout %22.076.1 28.9%   
Avg Mkt Cap Rs m32,272410,626 7.9%   
No. of employees `0001.15.0 21.8%   
Total wages/salary Rs m6615,372 12.3%   
Avg. sales/employee Rs Th6,132.26,306.7 97.2%   
Avg. wages/employee Rs Th611.11,083.1 56.4%   
Avg. net profit/employee Rs Th803.5898.0 89.5%   
INCOME DATA
Net Sales Rs m6,63531,281 21.2%  
Other income Rs m2421,023 23.7%   
Total revenues Rs m6,87732,304 21.3%   
Gross profit Rs m1,6046,009 26.7%  
Depreciation Rs m221486 45.6%   
Interest Rs m386 628.3%   
Profit before tax Rs m1,5876,540 24.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0287 0.0%   
Tax Rs m7182,373 30.3%   
Profit after tax Rs m8694,454 19.5%  
Gross profit margin %24.219.2 125.9%  
Effective tax rate %45.236.3 124.7%   
Net profit margin %13.114.2 92.0%  
BALANCE SHEET DATA
Current assets Rs m6,23220,061 31.1%   
Current liabilities Rs m1,49014,543 10.2%   
Net working cap to sales %71.517.6 405.2%  
Current ratio x4.21.4 303.2%  
Inventory Days Days8657 152.2%  
Debtors Days Days8314 587.5%  
Net fixed assets Rs m4,04314,343 28.2%   
Share capital Rs m1271,694 7.5%   
"Free" reserves Rs m8,18319,704 41.5%   
Net worth Rs m8,31021,398 38.8%   
Long term debt Rs m182 890.0%   
Total assets Rs m10,38939,113 26.6%  
Interest coverage x43.11,091.0 4.0%   
Debt to equity ratio x00 2,291.8%  
Sales to assets ratio x0.60.8 79.9%   
Return on assets %8.711.4 76.6%  
Return on equity %10.520.8 50.3%  
Return on capital %19.531.9 61.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,622534 1,052.8%   
Fx outflow Rs m1,7997,091 25.4%   
Net fx Rs m3,822-6,557 -58.3%   
CASH FLOW
From Operations Rs m3563,994 8.9%  
From Investments Rs m-279-1,433 19.4%  
From Financial Activity Rs m-225-3,584 6.3%  
Net Cashflow Rs m-148-1,023 14.5%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.0 10.2 -  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 102,036 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Higher; HCL Technologies & SBI Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a mixed note with stocks in the consumer durables sector.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 23, 2019 01:09 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS